APO Research
Talk to an analyst

APO RESEARCH · REPORT

Classical Swine Fever Vaccines

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).

Selected research

Industry Research

Classical Swine Fever Vaccines Industry Research Report 2026

21 December 2025131 pages

Choose your research edition.

Industry ResearchClassical Swine Fever Vaccines Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Classical Swine Fever Vaccines Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Classical Swine Fever Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Classical Swine Fever Vaccines Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Classical Swine Fever Vaccines Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).

The global classical swine fever vaccine market is dominated by Winsun, Merial and CAHIC, with the top three manufacturers accounting for about 60% of the market share. Asia Pacific is the largest market for classical swine fever vaccines, with a market share of about 50%, followed by Europe with a market share of about 25%. Tissue Culture Origin is the main type, with a share about 60%. Market Sales is the main application, which holds a share about 95%.

Report Scope

Read the full market overview

This report quantifies the global Classical Swine Fever Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (M Doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Doses) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Classical Swine Fever Vaccines Market by Company

WINSUN

Merial

CAHIC

Chopper Biology

MSD Animal Health (Merck)

ChengDu Tecbond

Ceva

Harbin Veterinary Research Institute

Qilu Animal Health Products Factory

Ringpu Biology

DHN

CAVAC

Komipharm

Agrovet

Bioveta

Jinyu Bio-Technology

Institutul Pasteur

MVP

Tecon

Classical Swine Fever Vaccines Segment by Source

Tissue Culture Origin

Cell Line Origin

Classical Swine Fever Vaccines Segment by Sales Channel

Government Tender

Market Sales

Classical Swine Fever Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Classical Swine Fever Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Classical Swine Fever Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Classical Swine Fever Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Classical Swine Fever Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Classical Swine Fever Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Classical Swine Fever Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by source, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by sales channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Source (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Sales Channel (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Classical Swine Fever Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Classical Swine Fever Vaccines Sales (M Doses) of Manufacturers (2021-2026) Table 7. Global Classical Swine Fever Vaccines Sales Market Share by Manufacturers (2021-2026) Table 8. Global Classical Swine Fever Vaccines Revenue of Manufacturers (2021-2026) Table 9. Global Classical Swine Fever Vaccines Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Classical Swine Fever Vaccines Average Price (US$/K Doses) of Manufacturers (2021-2026) Table 11. Global Classical Swine Fever Vaccines Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Classical Swine Fever Vaccines, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Classical Swine Fever Vaccines, Product Type & Application Table 14. Global Classical Swine Fever Vaccines Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Classical Swine Fever Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. WINSUN Company Information Table 19. WINSUN Business Overview Table 20. WINSUN Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 21. WINSUN Classical Swine Fever Vaccines Product Portfolio Table 22. WINSUN Recent Developments Table 23. Merial Company Information Table 24. Merial Business Overview Table 25. Merial Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 26. Merial Classical Swine Fever Vaccines Product Portfolio Table 27. Merial Recent Developments Table 28. CAHIC Company Information Table 29. CAHIC Business Overview Table 30. CAHIC Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 31. CAHIC Classical Swine Fever Vaccines Product Portfolio Table 32. CAHIC Recent Developments Table 33. Chopper Biology Company Information Table 34. Chopper Biology Business Overview Table 35. Chopper Biology Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 36. Chopper Biology Classical Swine Fever Vaccines Product Portfolio Table 37. Chopper Biology Recent Developments Table 38. MSD Animal Health (Merck) Company Information Table 39. MSD Animal Health (Merck) Business Overview Table 40. MSD Animal Health (Merck) Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 41. MSD Animal Health (Merck) Classical Swine Fever Vaccines Product Portfolio Table 42. MSD Animal Health (Merck) Recent Developments Table 43. ChengDu Tecbond Company Information Table 44. ChengDu Tecbond Business Overview Table 45. ChengDu Tecbond Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 46. ChengDu Tecbond Classical Swine Fever Vaccines Product Portfolio Table 47. ChengDu Tecbond Recent Developments Table 48. Ceva Company Information Table 49. Ceva Business Overview Table 50. Ceva Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 51. Ceva Classical Swine Fever Vaccines Product Portfolio Table 52. Ceva Recent Developments Table 53. Harbin Veterinary Research Institute Company Information Table 54. Harbin Veterinary Research Institute Business Overview Table 55. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 56. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Portfolio Table 57. Harbin Veterinary Research Institute Recent Developments Table 58. Qilu Animal Health Products Factory Company Information Table 59. Qilu Animal Health Products Factory Business Overview Table 60. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 61. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Portfolio Table 62. Qilu Animal Health Products Factory Recent Developments Table 63. Ringpu Biology Company Information Table 64. Ringpu Biology Business Overview Table 65. Ringpu Biology Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 66. Ringpu Biology Classical Swine Fever Vaccines Product Portfolio Table 67. Ringpu Biology Recent Developments Table 68. DHN Company Information Table 69. DHN Business Overview Table 70. DHN Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 71. DHN Classical Swine Fever Vaccines Product Portfolio Table 72. DHN Recent Developments Table 73. CAVAC Company Information Table 74. CAVAC Business Overview Table 75. CAVAC Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 76. CAVAC Classical Swine Fever Vaccines Product Portfolio Table 77. CAVAC Recent Developments Table 78. Komipharm Company Information Table 79. Komipharm Business Overview Table 80. Komipharm Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 81. Komipharm Classical Swine Fever Vaccines Product Portfolio Table 82. Komipharm Recent Developments Table 83. Agrovet Company Information Table 84. Agrovet Business Overview Table 85. Agrovet Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 86. Agrovet Classical Swine Fever Vaccines Product Portfolio Table 87. Agrovet Recent Developments Table 88. Bioveta Company Information Table 89. Bioveta Business Overview Table 90. Bioveta Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 91. Bioveta Classical Swine Fever Vaccines Product Portfolio Table 92. Bioveta Recent Developments Table 93. Jinyu Bio-Technology Company Information Table 94. Jinyu Bio-Technology Business Overview Table 95. Jinyu Bio-Technology Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 96. Jinyu Bio-Technology Classical Swine Fever Vaccines Product Portfolio Table 97. Jinyu Bio-Technology Recent Developments Table 98. Institutul Pasteur Company Information Table 99. Institutul Pasteur Business Overview Table 100. Institutul Pasteur Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 101. Institutul Pasteur Classical Swine Fever Vaccines Product Portfolio Table 102. Institutul Pasteur Recent Developments Table 103. MVP Company Information Table 104. MVP Business Overview Table 105. MVP Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 106. MVP Classical Swine Fever Vaccines Product Portfolio Table 107. MVP Recent Developments Table 108. Tecon Company Information Table 109. Tecon Business Overview Table 110. Tecon Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 111. Tecon Classical Swine Fever Vaccines Product Portfolio Table 112. Tecon Recent Developments Table 113. Global Classical Swine Fever Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 114. Global Classical Swine Fever Vaccines Sales by Region (2021-2026) & (M Doses) Table 115. Global Classical Swine Fever Vaccines Sales Market Share by Region (2021-2026) Table 116. Global Classical Swine Fever Vaccines Sales by Region (2027-2032) & (M Doses) Table 117. Global Classical Swine Fever Vaccines Sales Market Share by Region (2027-2032) Table 118. Global Classical Swine Fever Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 119. Global Classical Swine Fever Vaccines Revenue Market Share by Region (2021-2026) Table 120. Global Classical Swine Fever Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 121. Global Classical Swine Fever Vaccines Revenue Market Share by Region (2027-2032) Table 122. North America Classical Swine Fever Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. North America Classical Swine Fever Vaccines Sales by Country (2021-2026) & (M Doses) Table 124. North America Classical Swine Fever Vaccines Sales by Country (2027-2032) & (M Doses) Table 125. North America Classical Swine Fever Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Classical Swine Fever Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 127. Europe Classical Swine Fever Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Europe Classical Swine Fever Vaccines Sales by Country (2021-2026) & (M Doses) Table 129. Europe Classical Swine Fever Vaccines Sales by Country (2027-2032) & (M Doses) Table 130. Europe Classical Swine Fever Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe Classical Swine Fever Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 132. Asia Pacific Classical Swine Fever Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Asia Pacific Classical Swine Fever Vaccines Sales by Country (2021-2026) & (M Doses) Table 134. Asia Pacific Classical Swine Fever Vaccines Sales by Country (2027-2032) & (M Doses) Table 135. Asia Pacific Classical Swine Fever Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 136. Asia Pacific Classical Swine Fever Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 137. South America Classical Swine Fever Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. South America Classical Swine Fever Vaccines Sales by Country (2021-2026) & (M Doses) Table 139. South America Classical Swine Fever Vaccines Sales by Country (2027-2032) & (M Doses) Table 140. South America Classical Swine Fever Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 141. South America Classical Swine Fever Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa Classical Swine Fever Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2021-2026) & (M Doses) Table 144. Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2027-2032) & (M Doses) Table 145. Middle East and Africa Classical Swine Fever Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Classical Swine Fever Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 147. Global Classical Swine Fever Vaccines Sales by Source (2021-2026) & (M Doses) Table 148. Global Classical Swine Fever Vaccines Sales by Source (2027-2032) & (M Doses) Table 149. Global Classical Swine Fever Vaccines Sales Market Share by Source (2021-2026) Table 150. Global Classical Swine Fever Vaccines Sales Market Share by Source (2027-2032) Table 151. Global Classical Swine Fever Vaccines Revenue by Source (2021-2026) & (US$ Million) Table 152. Global Classical Swine Fever Vaccines Revenue by Source (2027-2032) & (US$ Million) Table 153. Global Classical Swine Fever Vaccines Revenue Market Share by Source (2021-2026) Table 154. Global Classical Swine Fever Vaccines Revenue Market Share by Source (2027-2032) Table 155. Global Classical Swine Fever Vaccines Price by Source (2021-2026) & (US$/K Doses) Table 156. Global Classical Swine Fever Vaccines Price by Source (2027-2032) & (US$/K Doses) Table 157. Global Classical Swine Fever Vaccines Sales by Sales Channel (2021-2026) & (M Doses) Table 158. Global Classical Swine Fever Vaccines Sales by Sales Channel (2027-2032) & (M Doses) Table 159. Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2021-2026) Table 160. Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2027-2032) Table 161. Global Classical Swine Fever Vaccines Revenue by Sales Channel (2021-2026) & (US$ Million) Table 162. Global Classical Swine Fever Vaccines Revenue by Sales Channel (2027-2032) & (US$ Million) Table 163. Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2021-2026) Table 164. Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2027-2032) Table 165. Global Classical Swine Fever Vaccines Price by Sales Channel (2021-2026) & (US$/K Doses) Table 166. Global Classical Swine Fever Vaccines Price by Sales Channel (2027-2032) & (US$/K Doses) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Classical Swine Fever Vaccines Distributors List Table 170. Classical Swine Fever Vaccines Customers List Table 171. Classical Swine Fever Vaccines Industry Trends Table 172. Classical Swine Fever Vaccines Industry Drivers Table 173. Classical Swine Fever Vaccines Industry Restraints Table 174. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Classical Swine Fever Vaccines Product Image Figure 5. Global Classical Swine Fever Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Classical Swine Fever Vaccines Market Size (2021-2032) & (US$ Million) Figure 7. Global Classical Swine Fever Vaccines Sales (2021-2032) & (M Doses) Figure 8. Global Classical Swine Fever Vaccines Average Price (US$/K Doses) & (2021-2032) Figure 9. Tissue Culture Origin Product Image Figure 10. Cell Line Origin Product Image Figure 11. Government Tender Product Image Figure 12. Market Sales Product Image Figure 13. Global Classical Swine Fever Vaccines Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Classical Swine Fever Vaccines, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Classical Swine Fever Vaccines Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Classical Swine Fever Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Classical Swine Fever Vaccines Sales by Region in 2025 Figure 19. Global Classical Swine Fever Vaccines Revenue by Region in 2025 Figure 20. North America Classical Swine Fever Vaccines Market Size by Country in 2025 Figure 21. North America Classical Swine Fever Vaccines Sales Market Share by Country (2021-2032) Figure 22. North America Classical Swine Fever Vaccines Revenue Market Share by Country (2021-2032) Figure 23. United States Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Classical Swine Fever Vaccines Market Size by Country in 2025 Figure 27. Europe Classical Swine Fever Vaccines Sales Market Share by Country (2021-2032) Figure 28. Europe Classical Swine Fever Vaccines Revenue Market Share by Country (2021-2032) Figure 29. Germany Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Classical Swine Fever Vaccines Market Size by Country in 2025 Figure 40. Asia Pacific Classical Swine Fever Vaccines Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Classical Swine Fever Vaccines Revenue Market Share by Country (2021-2032) Figure 42. China Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Classical Swine Fever Vaccines Market Size by Country in 2025 Figure 51. South America Classical Swine Fever Vaccines Sales Market Share by Country (2021-2032) Figure 52. South America Classical Swine Fever Vaccines Revenue Market Share by Country (2021-2032) Figure 53. Brazil Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Classical Swine Fever Vaccines Market Size by Country in 2025 Figure 57. Middle East and Africa Classical Swine Fever Vaccines Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Classical Swine Fever Vaccines Revenue Market Share by Country (2021-2032) Figure 59. Egypt Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries Classical Swine Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Classical Swine Fever Vaccines Sales Market Share by Source (2021-2032) Figure 65. Global Classical Swine Fever Vaccines Revenue Market Share by Source (2021-2032) Figure 66. Global Classical Swine Fever Vaccines Price (US$/K Doses) by Source (2021-2032) Figure 67. Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2021-2032) Figure 68. Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2021-2032) Figure 69. Global Classical Swine Fever Vaccines Price (US$/K Doses) by Sales Channel (2021-2032) Figure 70. Classical Swine Fever Vaccines Value Chain Figure 71. Classical Swine Fever Vaccines Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Classical Swine Fever Vaccines Industry Opportunities and Challenges

Scope & coverage.

Types
  • Tissue Culture Origin
  • Cell Line Origin
Applications
  • Government Tender
  • Market Sales
Companies covered
  • WINSUN
  • Merial
  • CAHIC
  • Chopper Biology
  • MSD Animal Health (Merck)
  • ChengDu Tecbond
  • Ceva
  • Harbin Veterinary Research Institute
  • Qilu Animal Health Products Factory
  • Ringpu Biology
  • DHN
  • CAVAC
  • Komipharm
  • Agrovet
  • Bioveta
  • Jinyu Bio-Technology
  • Institutul Pasteur
  • MVP
  • Tecon

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Classical Swine Fever Vaccines Market Size (2021-2032)
  4. 2.2.2 Global Classical Swine Fever Vaccines Sales (2021-2032)
  5. 2.2.3 Global Classical Swine Fever Vaccines Market Average Price (2021-2032)
  6. 2.3 Classical Swine Fever Vaccines by Source
  7. 2.3.1 Market Value Comparison by Source (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Tissue Culture Origin
  9. 2.3.3 Cell Line Origin
  10. 2.4 Classical Swine Fever Vaccines by Sales Channel
  11. 2.4.1 Market Value Comparison by Sales Channel (2021 VS 2025 VS 2032)
  12. 2.4.2 Government Tender
  13. 2.4.3 Market Sales
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Classical Swine Fever Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Classical Swine Fever Vaccines Sales (M Doses) of Manufacturers (2021-2026)
  3. 3.3 Global Classical Swine Fever Vaccines Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Classical Swine Fever Vaccines Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Classical Swine Fever Vaccines Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Classical Swine Fever Vaccines, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Classical Swine Fever Vaccines, Product Type & Application
  8. 3.8 Global Manufacturers of Classical Swine Fever Vaccines, Established Date
  9. 3.9 Global Classical Swine Fever Vaccines Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 WINSUN
  2. 4.1.1 WINSUN Company Information
  3. 4.1.2 WINSUN Business Overview
  4. 4.1.3 WINSUN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 WINSUN Classical Swine Fever Vaccines Product Portfolio
  6. 4.1.5 WINSUN Recent Developments
  7. 4.2 Merial
  8. 4.2.1 Merial Company Information
  9. 4.2.2 Merial Business Overview
  10. 4.2.3 Merial Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Merial Classical Swine Fever Vaccines Product Portfolio
  12. 4.2.5 Merial Recent Developments
  13. 4.3 CAHIC
  14. 4.3.1 CAHIC Company Information
  15. 4.3.2 CAHIC Business Overview
  16. 4.3.3 CAHIC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 CAHIC Classical Swine Fever Vaccines Product Portfolio
  18. 4.3.5 CAHIC Recent Developments
  19. 4.4 Chopper Biology
  20. 4.4.1 Chopper Biology Company Information
  21. 4.4.2 Chopper Biology Business Overview
  22. 4.4.3 Chopper Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Chopper Biology Classical Swine Fever Vaccines Product Portfolio
  24. 4.4.5 Chopper Biology Recent Developments
  25. 4.5 MSD Animal Health (Merck)
  26. 4.5.1 MSD Animal Health (Merck) Company Information
  27. 4.5.2 MSD Animal Health (Merck) Business Overview
  28. 4.5.3 MSD Animal Health (Merck) Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 MSD Animal Health (Merck) Classical Swine Fever Vaccines Product Portfolio
  30. 4.5.5 MSD Animal Health (Merck) Recent Developments
  31. 4.6 ChengDu Tecbond
  32. 4.6.1 ChengDu Tecbond Company Information
  33. 4.6.2 ChengDu Tecbond Business Overview
  34. 4.6.3 ChengDu Tecbond Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 ChengDu Tecbond Classical Swine Fever Vaccines Product Portfolio
  36. 4.6.5 ChengDu Tecbond Recent Developments
  37. 4.7 Ceva
  38. 4.7.1 Ceva Company Information
  39. 4.7.2 Ceva Business Overview
  40. 4.7.3 Ceva Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Ceva Classical Swine Fever Vaccines Product Portfolio
  42. 4.7.5 Ceva Recent Developments
  43. 4.8 Harbin Veterinary Research Institute
  44. 4.8.1 Harbin Veterinary Research Institute Company Information
  45. 4.8.2 Harbin Veterinary Research Institute Business Overview
  46. 4.8.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Portfolio
  48. 4.8.5 Harbin Veterinary Research Institute Recent Developments
  49. 4.9 Qilu Animal Health Products Factory
  50. 4.9.1 Qilu Animal Health Products Factory Company Information
  51. 4.9.2 Qilu Animal Health Products Factory Business Overview
  52. 4.9.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Portfolio
  54. 4.9.5 Qilu Animal Health Products Factory Recent Developments
  55. 4.10 Ringpu Biology
  56. 4.10.1 Ringpu Biology Company Information
  57. 4.10.2 Ringpu Biology Business Overview
  58. 4.10.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Ringpu Biology Classical Swine Fever Vaccines Product Portfolio
  60. 4.10.5 Ringpu Biology Recent Developments
  61. 4.11 DHN
  62. 4.11.1 DHN Company Information
  63. 4.11.2 DHN Business Overview
  64. 4.11.3 DHN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 DHN Classical Swine Fever Vaccines Product Portfolio
  66. 4.11.5 DHN Recent Developments
  67. 4.12 CAVAC
  68. 4.12.1 CAVAC Company Information
  69. 4.12.2 CAVAC Business Overview
  70. 4.12.3 CAVAC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 CAVAC Classical Swine Fever Vaccines Product Portfolio
  72. 4.12.5 CAVAC Recent Developments
  73. 4.13 Komipharm
  74. 4.13.1 Komipharm Company Information
  75. 4.13.2 Komipharm Business Overview
  76. 4.13.3 Komipharm Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Komipharm Classical Swine Fever Vaccines Product Portfolio
  78. 4.13.5 Komipharm Recent Developments
  79. 4.14 Agrovet
  80. 4.14.1 Agrovet Company Information
  81. 4.14.2 Agrovet Business Overview
  82. 4.14.3 Agrovet Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Agrovet Classical Swine Fever Vaccines Product Portfolio
  84. 4.14.5 Agrovet Recent Developments
  85. 4.15 Bioveta
  86. 4.15.1 Bioveta Company Information
  87. 4.15.2 Bioveta Business Overview
  88. 4.15.3 Bioveta Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Bioveta Classical Swine Fever Vaccines Product Portfolio
  90. 4.15.5 Bioveta Recent Developments
  91. 4.16 Jinyu Bio-Technology
  92. 4.16.1 Jinyu Bio-Technology Company Information
  93. 4.16.2 Jinyu Bio-Technology Business Overview
  94. 4.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Product Portfolio
  96. 4.16.5 Jinyu Bio-Technology Recent Developments
  97. 4.17 Institutul Pasteur
  98. 4.17.1 Institutul Pasteur Company Information
  99. 4.17.2 Institutul Pasteur Business Overview
  100. 4.17.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Institutul Pasteur Classical Swine Fever Vaccines Product Portfolio
  102. 4.17.5 Institutul Pasteur Recent Developments
  103. 4.18 MVP
  104. 4.18.1 MVP Company Information
  105. 4.18.2 MVP Business Overview
  106. 4.18.3 MVP Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 MVP Classical Swine Fever Vaccines Product Portfolio
  108. 4.18.5 MVP Recent Developments
  109. 4.19 Tecon
  110. 4.19.1 Tecon Company Information
  111. 4.19.2 Tecon Business Overview
  112. 4.19.3 Tecon Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Tecon Classical Swine Fever Vaccines Product Portfolio
  114. 4.19.5 Tecon Recent Developments
5 Global Classical Swine Fever Vaccines Market Scenario by Region
  1. 5.1 Global Classical Swine Fever Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Classical Swine Fever Vaccines Sales by Region: 2021-2032
  3. 5.2.1 Global Classical Swine Fever Vaccines Sales by Region: 2021-2026
  4. 5.2.2 Global Classical Swine Fever Vaccines Sales by Region: 2027-2032
  5. 5.3 Global Classical Swine Fever Vaccines Revenue by Region: 2021-2032
  6. 5.3.1 Global Classical Swine Fever Vaccines Revenue by Region: 2021-2026
  7. 5.3.2 Global Classical Swine Fever Vaccines Revenue by Region: 2027-2032
  8. 5.4 North America Classical Swine Fever Vaccines Market Facts & Figures by Country
  9. 5.4.1 North America Classical Swine Fever Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Classical Swine Fever Vaccines Sales by Country (2021-2032)
  11. 5.4.3 North America Classical Swine Fever Vaccines Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Classical Swine Fever Vaccines Market Facts & Figures by Country
  16. 5.5.1 Europe Classical Swine Fever Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Classical Swine Fever Vaccines Sales by Country (2021-2032)
  18. 5.5.3 Europe Classical Swine Fever Vaccines Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Classical Swine Fever Vaccines Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Classical Swine Fever Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Classical Swine Fever Vaccines Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Classical Swine Fever Vaccines Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Classical Swine Fever Vaccines Market Facts & Figures by Country
  41. 5.7.1 South America Classical Swine Fever Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Classical Swine Fever Vaccines Sales by Country (2021-2032)
  43. 5.7.3 South America Classical Swine Fever Vaccines Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Classical Swine Fever Vaccines Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Classical Swine Fever Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Classical Swine Fever Vaccines Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Source
  1. 6.1 Global Classical Swine Fever Vaccines Sales by Source (2021-2032)
  2. 6.1.1 Global Classical Swine Fever Vaccines Sales by Source (2021-2032) & (M Doses)
  3. 6.1.2 Global Classical Swine Fever Vaccines Sales Market Share by Source (2021-2032)
  4. 6.2 Global Classical Swine Fever Vaccines Revenue by Source (2021-2032)
  5. 6.2.1 Global Classical Swine Fever Vaccines Sales by Source (2021-2032) & (US$ Million)
  6. 6.2.2 Global Classical Swine Fever Vaccines Revenue Market Share by Source (2021-2032)
  7. 6.3 Global Classical Swine Fever Vaccines Price by Source (2021-2032)
7 Segment by Sales Channel
  1. 7.1 Global Classical Swine Fever Vaccines Sales by Sales Channel (2021-2032)
  2. 7.1.1 Global Classical Swine Fever Vaccines Sales by Sales Channel (2021-2032) & (M Doses)
  3. 7.1.2 Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2021-2032)
  4. 7.2 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2021-2032)
  5. 7.2.1 Global Classical Swine Fever Vaccines Sales by Sales Channel (2021-2032) & (US$ Million)
  6. 7.2.2 Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2021-2032)
  7. 7.3 Global Classical Swine Fever Vaccines Price by Sales Channel (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Classical Swine Fever Vaccines Value Chain Analysis
  2. 8.1.1 Classical Swine Fever Vaccines Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Classical Swine Fever Vaccines Production Mode & Process
  5. 8.2 Classical Swine Fever Vaccines Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Classical Swine Fever Vaccines Distributors
  8. 8.2.3 Classical Swine Fever Vaccines Customers
9 Global Classical Swine Fever Vaccines Analyzing Market Dynamics
  1. 9.1 Classical Swine Fever Vaccines Industry Trends
  2. 9.2 Classical Swine Fever Vaccines Industry Drivers
  3. 9.3 Classical Swine Fever Vaccines Industry Opportunities and Challenges
  4. 9.4 Classical Swine Fever Vaccines Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst